Abilify and Amphotericin b drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Amphotericin b (amphotericin b). Common drug interactions include spinal fracture among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Amphotericin b. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Amphotericin b?

Amphotericin b has active ingredients of amphotericin b. It is often used in thrush. eHealthMe is studying from 16,275 Amphotericin b users. Check the latest studies of Amphotericin b.

On Jul, 10, 2026

13 people who take Abilify and Amphotericin b together, and have interactions are studied.

Abilify and Amphotericin b drug interactions.

What are the common drug interactions of Abilify and Amphotericin B, by gender? *:

female:

Spinal fracture (fracture in one of vertebrae)
Fall
Localised infection (infection at the single location)
Neck injury
Scoliosis (a medical condition in which a person's spine is curved from side to side)
Arthralgia (joint pain)
Infusion site infection
Injection site infection
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Foetal malnutrition (soft tissue wasting at birth)

male:

Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Pyrexia (fever)
Sinusitis (inflammation of sinus)
Sinusitis fungal (fungal infection of sinus)
Gastric disorder (disease of stomach)
Death
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)

What are the common drug interactions of Abilify and Amphotericin B, by age (0-1 to 60+)? *:

0-1:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Foetal malnutrition (soft tissue wasting at birth)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Arthralgia (joint pain)
Infusion site infection
Death
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Injection site infection
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
Pyrexia (fever)
Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 53.85%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 23.08%
Asthma: 3 people, 23.08%
Panic Disorder: 2 people, 15.38%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 15.38%
Stress And Anxiety: 1 person, 7.69%
Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
Oral Candidiasis (fungal infection of mouth): 1 person, 7.69%
Fungal Infection: 1 person, 7.69%
Agitation (state of anxiety or nervous excitement): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Amphotericin b?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously